Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of OPC-262 in Type 2 Diabetes
NCT01046318Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Kyowa Kirin. Started Nov 2009; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01046318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046318.